Philips announces FDA approval for enhanced LumiGuide guidewire and marks the 1000th patient treated with its breakthrough 3D device guidance technology
By clicking on the link, you will be leaving the official Royal Philips ("Philips") website. Any links to third-party websites that may appear on this site are provided only for your convenience and in no way represent any affiliation or endorsement of the information provided on those linked websites. Philips makes no representations or warranties of any kind with regard to any third-party websites or the information contained therein.
What's trending
News
Philips strengthens strategic partnership with Sim&Cure to expand innovation in neurovascular therapy
Click here to learn morePhilips announces FDA approval for enhanced LumiGuide guidewire and marks the 1000th patient treated with its breakthrough 3D device guidance technology
Click here to learn morePhilips enrolls first patient in U.S. clinical trial for innovative integrated single-device to treat peripheral artery disease
Click here to learn more